Benson Chen

University of Auckland — New Zealand

Medicine · Health Sciences

16h-index1.0kcitations70works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cerebral Venous Sinus Thrombosis(13), Mitochondrial Function and Pathology(10), Computational Drug Discovery Methods(7), Machine Learning in Materials Science(7), Retinal Development and Disorders(6)

Publications70 total

The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy
Trials·2025· 1 citedOpen Access
Rasch analysis of the NEI-VFQ-25: vision-related quality of life in Leber hereditary optic neuropathy after lenadogene nolparvovec gene therapy
BMJ Open Ophthalmology·2025· 1 citedOpen Access
Myelination of the retinal nerve fibre layer: A case report
Multiple Sclerosis Journal·2025· 1 citedOpen Access
“Adrift From the World”: Exploring the Lived Experiences of Individuals Affected by an Inherited Optic Neuropathy in the United Kingdom—A Qualitative Study
Value in Health·2025
Technological advances in the diagnosis and management of inherited optic neuropathies
Frontiers in Neurology·2025Open Access
The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy
2025· 1 citedOpen Access
Clinical trials in Leber hereditary optic neuropathy: outcomes and opportunities
Current Opinion in Neurology·2024· 9 cited
‘Adrift from the World’: Understanding how Inherited Optic Neuropathies Impact on Quality of Life (S40.002)
Neurology·2024· 1 cited
Visual outcome measures in clinical trials of remyelinating drugs
BMJ Neurology Open·2024· 6 citedOpen Access
Contributors
Elsevier eBooks·2024
Pathophysiology of spontaneous cerebrospinal fluid leaks and their relationship with idiopathic intracranial hypertension
Elsevier eBooks·2024
Compositional Deep Probabilistic Models of DNA Encoded Libraries
arXiv (Cornell University)·2023· 1 citedOpen Access
Mitochondria and the eye—manifestations of mitochondrial diseases and their management
Eye·2023· 31 citedOpen Access
Blurred Disc Margins
Journal of Neuro-Ophthalmology·2023
Psychometric Validity of the Visual Function Index in Leber Hereditary Optic Neuropathy
Translational Vision Science & Technology·2023· 4 citedOpen Access
Childhood-Onset Leber Hereditary Optic Neuropathy—Clinical and Prognostic Insights
American Journal of Ophthalmology·2022· 16 cited
DEL-Dock: Molecular Docking-Enabled Modeling of DNA-Encoded Libraries
arXiv (Cornell University)·2022· 1 citedOpen Access
Expanding the clinical spectrum of idiopathic intracranial hypertension
Current Opinion in Neurology·2022· 25 citedOpen Access
Developments in the Treatment of Leber Hereditary Optic Neuropathy
Current Neurology and Neuroscience Reports·2022· 36 citedOpen Access
Pathogenic RUNX1 C-Terminal Truncation Mutations Contribute to Differentiation Block and Result in Unique Changes in Transcription and Chromatin Organization
Blood·2022
page 1 of 4Next →

Frequent Co-authors

Patrick Yu‐Wai‐Man(12), Nancy J. Newman(9), Valérie Biousse(8), Amit M. Saindane(6), Bonnie Bruce(5), Tommi Jaakkola(5), Regina Barzilay(5), Benjamin I. Meyer(4), Gioia Riboni-Verri(4), Nick Cunniffe(4), Neil E. Anderson(3), Magali Taiel(3), Julian D. Perry(3), Mike Horton(3), Christopher E McMurran(3), J William L Brown(3), Alasdair Coles(3), Rabin Gautam(3), Barry Snow(2), Arnold Bok(2)